Lyell Immunopharma, Inc. LYEL · Insights

website

161

Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor ...

Price15.42

Market Cap493.65 M

Float18.84 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Key Dates & Timelines

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro

Financial Transactions

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro